David S. Wang

3.5k total citations
90 papers, 2.3k citations indexed

About

David S. Wang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, David S. Wang has authored 90 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 30 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in David S. Wang's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Pediatric Urology and Nephrology Studies (10 papers) and Kidney Stones and Urolithiasis Treatments (7 papers). David S. Wang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Pediatric Urology and Nephrology Studies (10 papers) and Kidney Stones and Urolithiasis Treatments (7 papers). David S. Wang collaborates with scholars based in United States, Australia and Italy. David S. Wang's co-authors include Lloyd C. L. Hollenberg, Austin G. Fowler, Michael Kuo, Jürgen K. Willmann, Soonmee Cha, Maximilian Diehn, Susan L. McGovern, Christine Nardini, Kenneth Aldape and Mahesh Jayaraman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and Circulation.

In The Last Decade

David S. Wang

81 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David S. Wang United States	24	585	568	471	422	356	90	2.3k
Spencer C. Behr United States	26	981 1.7×	1.0k 1.8×	503 1.1×	178 0.4×	280 0.8×	138	2.9k
Jean‐Paul Vallée Switzerland	34	670 1.1×	1.5k 2.7×	615 1.3×	84 0.2×	422 1.2×	149	3.3k
Alan H. Stolpen United States	26	640 1.1×	876 1.5×	531 1.1×	83 0.2×	102 0.3×	69	2.7k
Simon Turcotte Canada	24	427 0.7×	1.0k 1.8×	390 0.8×	305 0.7×	431 1.2×	72	4.8k
Jacob Sosna Israel	30	792 1.4×	1.3k 2.2×	567 1.2×	155 0.4×	1.0k 2.9×	138	3.3k
N. Moriyama Japan	26	1.3k 2.3×	1.1k 1.9×	573 1.2×	156 0.4×	178 0.5×	93	3.0k
James P.B. O’Connor United Kingdom	32	979 1.7×	3.3k 5.9×	274 0.6×	215 0.5×	792 2.2×	117	4.8k
Robert Grimm Germany	30	582 1.0×	2.6k 4.6×	302 0.6×	88 0.2×	286 0.8×	148	3.2k
MingDe Lin United States	37	925 1.6×	2.0k 3.5×	680 1.4×	303 0.7×	799 2.2×	152	4.0k

Countries citing papers authored by David S. Wang

Since Specialization

Citations

This map shows the geographic impact of David S. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Wang more than expected).

Fields of papers citing papers by David S. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Wang. The network helps show where David S. Wang may publish in the future.

Co-authorship network of co-authors of David S. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Wang. A scholar is included among the top collaborators of David S. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Wang. David S. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Babayan, Richard K., et al.. (2024). Clinical, Diagnostic, and Metabolic Characteristics Associated with Nephrolithiasis in the Black Women’s Health Study. Journal of Clinical Medicine. 13(19). 5948–5948. 2 indexed citations

Bui, Nam Q., Neda Nemat‐Gorgani, Matt van de Rijn, et al.. (2023). Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA Analysis. Clinical Cancer Research. 29(14). 2612–2620. 9 indexed citations

Browne, William F., Bill S. Majdalany, Minhaj S. Khaja, et al.. (2023). ACR Appropriateness Criteria® Sudden Onset of Cold, Painful Leg: 2023 Update. Journal of the American College of Radiology. 20(11). S565–S573.

Apoj, Michel, et al.. (2022). Assessing the readability and quality of online information about benign prostatic hyperplasia. World Journal of Urology. 41(1). 257–262. 1 indexed citations

Wason, Shaun, et al.. (2021). A case of epididymoorchitis without testicular infarction presenting with reversal of diastolic testicular flow on Doppler ultrasonography. Urology Case Reports. 38. 101694–101694.

Gaba, Ron C., Robert J. Lewandowski, Ryan Hickey, et al.. (2016). Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria. Journal of Vascular and Interventional Radiology. 27(4). 457–473. 90 indexed citations

Chowdhury, Sayan Mullick, Tzu-Yin Wang, Sunitha V. Bachawal, et al.. (2016). Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs. Journal of Controlled Release. 238. 272–280. 58 indexed citations

Wang, David S., et al.. (2016). Diagnosis and Management of Hematuria. Surgical Clinics of North America. 96(3). 503–515. 23 indexed citations

Wang, David S., Fumikiyo Ganaha, Jane Lee, et al.. (2015). Local Stent-Based Release of Transforming Growth Factor–β1 Limits Arterial In-Stent Restenosis. SLAS TECHNOLOGY. 21(2). 305–311. 5 indexed citations

10.

Carrasquillo, Robert, et al.. (2014). 5-Alpha-reductase inhibitors in diseases of the prostate. Current Opinion in Endocrinology Diabetes and Obesity. 21(6). 488–492. 2 indexed citations

11.

Hill, Charles D., Austin G. Fowler, David S. Wang, & Lloyd C. L. Hollenberg. (2013). Fault-tolerant quantum error correction code conversion. Quantum Information and Computation. 13(5). 439–451. 7 indexed citations

12.

Panje, Cédric, David S. Wang, & Jürgen K. Willmann. (2013). Ultrasound and Microbubble–Mediated Gene Delivery in Cancer. Investigative Radiology. 48(11). 755–769. 39 indexed citations

13.

Dickstein, Rian J., et al.. (2011). Predictors for Negative Ureteroscopy in the Management of Upper Urinary Tract Stone Disease. Urology. 78(4). 748–752. 14 indexed citations

14.

Fowler, Austin G., David S. Wang, Charles D. Hill, et al.. (2010). Surface Code Quantum Communication. Physical Review Letters. 104(18). 180503–180503. 117 indexed citations

15.

Wang, David S., Michael D. Dake, Jinha Park, & Michael Kuo. (2009). Molecular Imaging: A Primer for Interventionalists and Imagers. Journal of Vascular and Interventional Radiology. 20(7). S505–S522. 2 indexed citations

16.

Diehn, Maximilian, Christine Nardini, David S. Wang, et al.. (2008). Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proceedings of the National Academy of Sciences. 105(13). 5213–5218. 345 indexed citations

17.

Wang, David S., Michael D. Dake, Jinha Park, & Michael Kuo. (2006). Molecular Imaging: A Primer for Interventionalists and Imagers. Journal of Vascular and Interventional Radiology. 17(9). 1405–1423. 14 indexed citations

18.

Amabile, Philippe, David S. Wang, Jane Lee, et al.. (2005). Directed Migration of Smooth Muscle Cells to Engineer Plaque-Resistant Vein Grafts. Journal of Endovascular Therapy. 12(6). 667–675. 4 indexed citations

19.

Young, Sarah, Fumikiyo Ganaha, Hiroki Minamiguchi, et al.. (2004). In-Stent Restenosis Limitation with Stent-based Controlled-Release Nitric Oxide: Initial Results in Rabbits. Radiology. 230(2). 377–382. 30 indexed citations

20.

Wang, David S., Kimberly Rieger‐Christ, Jerilyn M. Latini, et al.. (2000). Molecular analysis ofPTEN andMXI1 in primary bladder carcinoma. International Journal of Cancer. 88(4). 620–625. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact